Application Deadline: 20/12/2018
Ref: PS-FIN
The Finance Unit is looking for a Procurement Specialist to assure that the Official Tenders of the Research Center are completed with efficiency, accurately an in a timely manner.
IBEC’s Biomedical Signal Processing and Interpretation (BIOSPIN) group have published a paper with King’s College London that offers new techniques to monitor COPD patients by non-invasive methods.COPD – chronic obstructive pulmonary disease – is a progressive lung condition with no cure in which the patient’s airways become narrowed. Together with other mechanical abnormalities, airways obstruction increases the load on the respiratory muscles. This, in combination with respiratory muscle weakness in COPD patients, increases load-capacity imbalance and contributes to breathlessness. The IBEC group’s paper elucidates a new way of assessing inspiratory muscle function using mechanomyography, a non-invasive measure of muscle vibration associated with muscle contraction, jointly with surface electromyography.
The nanoBio&Med2018 International Conference opened today with IBEC Director Josep Samitier chairing the first round of talks, in which group leader Samuel Sanchez is the first speaker.Other IBEC speakers and participants throughout the three-day event will include Rafael Mestre, Anna Lagunas, Silvia Pujals, Xavier Arqué and Samuel Ojosnegros, as well as UCL’s Giuseppe Battaglia, who will join the institute soon.
Taking place at the PCB, the IBEC-supported event – now in its fourth year – presents the most recent international developments in the fields of nanobiotechnology and nanomedicine and will provide a platform for multidisciplinary communication, new cooperations and projects to participants from both science and industry.
PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
PhD Discussion sessions are open to all staff and researchers at all career stages, and are intended to help PhD students gain feedback from colleagues by presenting their research results and discussing them with each other, as well as with more experienced researchers.
Application Deadline: 10/12/2018
Ref: PD-SMU
The Targeted therapeutics and nanodevices group led by Dr. Silvia Muro at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral candidate to work on the design of nanocarriers to transport drugs to the brain. The contract will be framed around a funded Explora Ciencia / Tecnología project, which aims to investigate the biological mechanisms controlling transport into and across the blood-brain barrier (BBB) to then design polymeric nanovehicles with optimal properties for brain delivery of therapeutics in the context of neurodegenerative diseases.
Application Deadline: 10/12/2018
Ref: PD-EM
The Biomimetic systems for cell engineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral Researcher candidate to to develop his/her project on the development of a physiological in vitro model of the intestinal epithelium from using organoid-derived cells.
The contract will be within the framework of the project “Engineering complex models of intestinal epithelium”, whose objective is the development of tissue-like models of intestinal tissue that can be used in basic research, disease modeling, host-pathogen interaction studies, and regenerative medicine.
Researchers at IBEC and IDIBELL have developed a light-regulated molecule that could improve chemotherapy treatments by controlling the activity of anticancer agents.Chemotherapy – the use of cytotoxic agents to kill the rapidly proliferating cells in tumors – is one of our main tools in the fight against cancer. However, its effectiveness and the body’s tolerance of it is often dramatically limited: it can affect healthy areas rather than just the cancerous ones, which causes side effects.